Viewing Study NCT01232504

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 9:12 PM

Ignite Modification Date: 2025-12-28 @ 10:13 PM

Study NCT ID: NCT01232504

Status: COMPLETED

Last Update Posted: 2014-11-04

First Post: 2010-10-25

Is Gene Therapy: True

Has Adverse Events: True

Brief Title: Antifugal Effect of Recombinant Human Granulocyte-macrophage Stimulating Factor (rhGM-CSF) in Patients Post Allo-HSCT

Sponsor: Xiamen Amoytop Biotech Co., Ltd.

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module Adverse Events Module Baseline Characteristics Module Participant Flow Module